INTRODUCTION
Complex processes such as cell growth, differentiation, and migration require the integration of multiple types of extracellular signals, including those delivered by growth factors, cytokines, cell adhesion molecules and extracellular matrix (ECM) proteins [1] . Most signaling pathways involve changes in cellular tyrosyl phosphorylation which are regulated by a diverse family of protein tyrosine kinases (PTKs) and an equally diverse family of protein tyrosine phosphatases (PTPs) [2] . SHP-1 and SHP-2 comprise a subfamily of tyrosine-specific cytoplasmic PTPs, with roles in hematopoiesis, bone formation and vasculogenesis [3] [4] [5] [6] . Whilst SHP-1 and SHP-2 share approximately 60% overall sequence identity, contain two SH2 domains and a catalytic domain, they exhibit distinct physiological functions. SHP-1 is predominantly expressed in haematopoietic cells and is a negative regulator of phosphotyrosine signaling [7] [8] [9] , whereas SHP-2 is ubiquitously expressed and is considered to be a positive mediator of hematopoiesis [4, 8, 10, 11] . These molecules are cytoplasmic tyrosine phosphatases, each containing two unique SH2
domains which bind to a distinct amino acid sequence surrounding a phosphotyrosine residue.
Evidence for the functional importance of SHP-1 and SHP-2 comes from the analyses of shp-1 and shp-2 mutant knock-out organisms. SHP-1 motheaten (me) and motheaten viable (me v ) [7] mice suffer from immune deficiency and autoimmune diseases and exhibit hematopoietic abnormalities, e.g. excessive erythropoiesis, augmented granulocyte and monocyte production and tissue accumulation, overexpansion of CD5 + B cells, leukocyte hypersensitivity and deregulated mast cell and defective T and NK cell functions [7, 10, 12] . In contrast, disruption of the mouse SHP-2 gene causes death of the embryos at midgestation, highlighting its importance in development. Moreover, fibroblasts from mice harbouring a deletion of SHP-2 exon 3, which express low levels of a defective SHP-2 protein that lacks its N-terminal SH2 domain [13] exhibit impaired mitogen-activated protein kinase (MAPK) activation in response to fibroblast growth factor (FGF), epidermal growth factor (EGF), and insulin-like growth factor I (IGF-I) [13, 14] . In other pathways, however, SHP-2 binds to distinct signaling intermediates. One class of SHP-2 binding proteins, exemplified by the Drosophila daughter of sevenless (dos) gene product, consists of an N-terminal pleckstrin homology domain, multiple proline-rich stretches and potential tyrosyl phosphorylation sites [15] . A second class of molecules belonging to the Ig-ITIM I. Rappold and M. Raida. Peripheral blood (PB), posterior iliac crest bone marrow (BM) and umbilical cord blood (UCB) mononuclear cells were collected with informed consent and ethical approval [19] [20] [21] . U937 cells were cultured in 10% FCS RPMI-1640 medium containing 10 -7 M 12-O-tetradecanoylphorbol 13-acetate (TPA) (Sigma Chemical Co) as a differentiating agent for 4 days to induce monocytic differentiation characterised using α-naphthyl acetate non specific esterase staining [22] . The WM78 mAb was derived after immunization of BALB/c mice with the human T cell line, 8402, and fusion of spleen cells with the SP2/0 myeloma cell line [23] . [20, 21] . Isolated were labeled with CD34-PE (phycoerythrin), AC133/2-PE or CD14-PE mAbs and were routinely >95% pure.
In Situ Immunofluorescence Staining
HBMSC cultured in 8-chamber slide flasks (Nunc Inc. Naperville, IL), were fixed in acetone/methanol (1:1), blocked with 5% (v/v) normal goat serum (NGS) and stained with the WM78 mAb or an isotype-matched mIgG1 control followed by FITC (fluorescein isothiocyanate) -conjugated goat anti-mouse F(ab) 2 Ig (Silenius, Hawthorn, Vic., Australia) [20] . Cells were examined under an Olympus BH2-RFCA fluorescence microscope (Olympus Microsystems, London, England).
Flow Cytometry and sorting
For single color analyses, cells were stained as described [21] . FITC, followed by WM78-biotin plus streptavidin-PE or CD3-PE followed by WM78-biotin plus streptavidin-FITC [21] . For triple color labeling, cells were stained with CD34-FITC (clone 8G12) and CD38-PE (clone HB-7), plus WM78-biotin and streptavidin-tricolor (TC; Caltag Laboratories, Burlingame, CA) [20] . BMMNCs were FcR blocked and stained with CD34-PE (clone 8G12) and WM78-biotin followed by streptavidin-TC and sorted on the FACStar PLUS (Becton-Dickinson, Sunnyvale, CA) [23] .
Clonogenic Assays and Pre-Progenitor Cell (Pre-CFU) Culture
Cells were assayed for day 14 granulocyte-macrophage (CFU-GM), and/or granulocyte (CFU-G) and macrophage (CFU-M) colony forming cells, early erythroid progenitors (BFU-E) and multipotential colony forming cell (CFU-Mix) in semi-solid methylcellulose cultures [19, 23] . All colonies were scored according to standard criteria after 14 days incubation. Sorted cells were cultured in pre-CFU medium containing a cocktail of six haematopoietic growth factors (6HGF)
rhu IL-1, IL-3, IL-6, G-CSF, GM-CSF and SCF, all at 10 ng/ml, for 28 days [25] .
Immunoprecipitation and SDS -PAGE
Goat anti-mouse Ig-coupled Dynabeads (Dynal) were pre-armed with purified immunoglobulin (WM78 and isotype matched non-binding controls) as described previously [26] . Samples were run on 10% (w/v) SDS-polyacrylamide gel electrophoresis (SDS-PAGE) [27] , transferred to polyvinyldifluoroacetate membranes (PVDF; MSI Membranes, Bresatec, Adelaide, Australia) and developed with streptavidin-alkaline phosphatase (AP; Amersham Int, Little Chalfton, Berks., England). Immunoreactive proteins were resolved using a FluorImager and ImageQuant software (both from Molecular Dynamics, Sunnyvale, CA).
Expression Cloning and Sequencing of the WM78 cDNA Clone
The PZRa cDNA was isolated from a human bone marrow stromal cell (HBMSC) cDNA library in the retroviral vector pRUFneo [23] Copyright 2002 Biochemical Society were reverse transcribed using Sensiscript Reverse Transcriptase system (Qiagen Ltd.). Human PZR, PZRa and PZRb were generated by PCR amplification of the cDNAs described above using appropriate forward and reverse primers (Sigma Chemical Co.) and the Expand TM Long PCR system (Boehringer-Mannheim) [19] . The cDNAs were ligated into the pGEM-T easy vector (Promega) and PCR amplified using the Expand TM Long Template System (Boehringer-Mannheim) and PUC M13 forward and reverse primers [19] . The PZR, PZRa and PZRb PCR products were sequenced automatically on an ABI 377 Automatic Sequencer (Perkin-Elmer-Applied Biosystems) [19] . Peptide motifs and structural characteristics were predicted using TopPred 2, Das, Signal P, TMHMM, O-Glycbase, Net Phos 2.0 Server and MacVector software packages [19] .The PZR and PZRb TaqMan TM (Applied Biosystems) systems consist of the the following pair of primers: FPZR
was not quantified by this method because it was not found in high levels in the majority of cells tested and because the sets of primers and fluorescent probes that can be designed in the region that distinguish PZRa from the other two isoforms (the 3' part of exon 4) can amplify genomic DNA.
The reaction was set up as described in Chiu et al [29] . The difference in the levels of expression between PZR and PZRb in different haematopoietic cells was given by the ∆Ct value: ∆Ct=| CtPZR -CtPZRb|. The relative expression ratio between the two molecules was calculated using the following formula: 2 |∆Ct| . All the experiments were carried out in duplicate on 4 independent occasions.
PZR Genomic PAC and Cosmid DNA Clones and Southern Blots
Three PZRa cDNA probes were used for screening human genomic libraries and subclones and for Southern blotting (see Figure 7 ). Probe A used for screening a human leukocyte PAC library was derived from the BamHI/XhoI fragment of PZRa cDNA in the pGEM-T vector. Probe B (366bp), used to probe the human chromosome 1 specific cosmid library, was generated by BamHI and Hind II digestion of the PZRa cDNA, while probe C was a PCR product generated from the PZRa. Each cDNA probe was labeled with 30µCi α-32 P-dCTP (Amersham Int.) using the T7 Quickprime kit (Pharmacia-Biotech AB) or with the DIG labeling kit (Roche Diagnostics, Mannheim, Germany) [19, 20] . The human PAC library was hybridized with α- or PCR amplified using a range of primer pairs and the ah95b1 cosmid clone was selected for detailed analysis. Human PAC, cosmid and human leukocyte genomic DNA (Promega) samples were further analysed using PZRa probes A, B or C (see Figure 7 ) labeled with α-32 P-dCTP or with DIG (Roche Diagnostics) [19] . PAC and cosmid DNAs were analyzed by PCR amplification using appropriate primers, the Expand TM Long PCR System (Boehringer Mannheim) and the PCR program described above. Human genomic DNA was PCR amplified as above in order to verify the 
Fluorescence in situ Hybridization (FISH) and In silico cloning
Metaphase spreads were prepared from phytohemagglutinin-stimulated normal human lymphocytes probed with the biotinylated ah95b1 cosmid clone as described previously [21] . Neither exon 1 nor and the first 1.5 kb of intron 1 were present in the 313-L4 PAC or ah95-b1 cosmid clone sequences.
Since we located the PZR gene on human chromosome 1q24, and since the Homo Sapiens chromosome 1 working draft sequence had been determined by the Sanger Centre and provided by the NCBI, the sequence of exon 1 and intron 1 was identified in silico (Genbank database, Accession number: NT004668).
Production of MEF cell lines stably expressing PZR isoforms
Mouse embryonic fibroblasts (MEFs) were used as SHP- XhoI and subcloned into the multiple cloning site of the pRUF. Neo retroviral vector and transfected into the ψ 2 [23] . Cells were selected in 400µg/ml G418 prior to transfer into G418 free medium DMEM for virus collection and retroviral infection of the MEF cells [23] . Flow cytometry and immunoprecipitation identified PZR, PZRb and PZRa proteins of 48, 36 and 34 kD using the WM78 mAb (data not shown). The top 50% of the cells expressing PZR were isolated by flow sorting as above, cultured in 400µg/ml G418 and used in the migration assay [23] .
Migration Assay
The underside of transwell 8µm pore filter was coated in triplicate with either 1 ml of 10µg /ml fibronectin (Boehringer Mannheim) or 10µg/ml BSA as a control, for 2 hours at 37 0 C or overnight at 4 0 C. Twenty four hours prior to seeding the cells onto the transwell filter (Costar  Corning, NY, 9 added to the upper chamber of the transwells. 500µl of serum free media containing 4µg/ml of fibronectin was added to the lower chamber and incubated at 37 0 C for 5 hours. Cells which migrated through the filter were fixed in 3.7% (w/v) paraformaldehyde for 10 mins and stained with 0.2% (w/v) crystal violet in ethanol (ICN Biomedicals, Inc., Costa Mesa, CA, USA) for 20 mins at room temperature Crystal violet was extracted using 300µl of 10% (v/v) acetic acid for 5 mins at room temperature on a shaker. The results were quantified using a Beckman D4-65 spectophotometer at 600nm wavelength. Data points derived from 3 independent experiments are reported as the mean ± standard error of the mean (SEM). Analysis of the variance to determine significant differences between treatments was performed using ANOVA Factorial analyses.
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RESULTS
The Monoclonal Antibody WM78 Identifies an Antigen Expressed by Bone Marrow
Mesenchymal and Peripheral Blood Mononuclear Cells
The WM78 mAb was selected for its reactivity with bone marrow derived mesenchymal or cultured stromal/osteoblast cells (Figure 1a) . However, its reactivity was not restricted to these cells. Figure 1b illustrates database analyses revealed substantial nucleotide homology to the previously cloned PZR molecule that is expressed in epithelial cells [17] . We named this molecule PZRa (Genbank accession 
Identification of PZR Isoforms in Hematopoietic, Endothelial and Mesenchymal Cells
Since our studies revealed that PZR and PZRa contained different cytoplasmic sequences but identical extracellular and transmembrane domain sequences, we PCR amplified cDNAs using an identical forward primer (FPZR positioned at -17 from the ATG) but different reverse primers to sequences in the 3' UTRs that would specifically distinguish between PZR and PZRa gene products, namely R904 and R974 repsectively ( Figure 5 ). Initial PCR analyses, using these primer pairs with the Raji and KG1A cDNAs, generated three rather than two different products. One product of approximately 650 bp produced with the primer pair, FPZR and R904, was detected only after 60 cycles of PCR amplification and was identical to the PZRa sequence ( Figure 5 ). The other two products that were generated using the primer pair FPZR and R974 were approximately 900 and 700 bp in size and were generated with 30 cycles of PCR amplification (Figure 6a ).
Sequence analysis demonstrated that the larger product was identical to PZR ( Figure 5 ) whereas the smaller product was identical to PZR in its extracellular and transmembrane domains, but not in its cytoplasmic tail. We have termed this product, PZRb ( 
Amino acid Sequence Identity and Potentially Important Motifs for the PZR Isoforms
The amino acid sequence similarities and predicted structures of the three PZR-like peptides are 
Genomic Structural Analyses Reveal that the PZR Isoforms are Derived by Differential
Splicing of a Single Gene Transcription Unit and are Located on Human Chromosome 1q24
To determine if the PZR isoforms are products of one or more genes, we analyzed the genomic to +609. This is followed by a 3' UTR sequence of at least 541bp. Similarly, for both the PZR and PZRb transcripts, exon 4 starts at +473 bp and reads through to +605 bp. However, unlike PZRa, both PZR and PZRb then use a dinucleotide GT splice site one base before the stop codon of PZRa to splice onto additional exons. PZR splices onto exon 5, which comprises 103 bps and covers +606
to +705 bps of the mRNA sequence, which then splices onto exon 6 which encompasses +706 to +1019 bps, with a TAA stop codon located at +808 to +810 bps. PZRb splices from exon 4 onto exon 6 at +606 bp but reads through to a TAG stop codon at +628 bp. From the cDNA sequence, we would predict a minimum 3' UTR sequence of 123 bp. Metaphase spreads were examined using the 95b1 cosmid clone containing the PZR gene as a probe. Positive signals were observed on both chromatides of human chromosome 1 at band 1q24 ( Figure 8 ).
PZR, but not PZRa or PZRb, Regulates Integrin-Mediated Cell Motility
Stable transfectants were analysed for their relative expression levels of the PZR isoforms using flow cytometry with the WM78 mAb. A representative set of histograms ( Figure 9a ) shows a relatively uniform mean fluoresence intensity for each of the transfectants. Using these cells, we investigated the effects of SHP-2 depletion in relation to PZR and its various isoforms on migration over the extracellular matrix protein, fibronectin. Previous studies have indicated that the SHP-2 mutant cells (∆46-110) migrate at a slower rate than the SHP-2 rescue cells [30] and that the mutant SHP-2 protein without the intact N-SH2 domain (∆46-110) does not function in a dominant negative manner but rather as a loss-of-function molecule [14] . Thus, the availability of the SHP-2 rescue, "wild type" fibroblast cell line, where SHP-2 had been re-introduced into SHP-2 -/-cells together with the homozygous SHP-2 -/-mutant (∆46-110) fibroblast cell line, provided us with a unique opportunity to study PZR-mediated effects in a SHP-2 positive or negative background.
Using a transwell migration chamber with 8µm pores, the migration of uninfected wild-type and SHP-2 -/-(∆46-110) MEF cells was compared with the migration of the PZR isoform expressing MEF cell lines on BSA or fibronectin. As shown in Figure 9b , no significant migration was observed using BSA as the chemotactic stimulus. In contrast, in 3 independent experiments, migration was increased to variable levels with all cell lines using fibronectin as the integrin-mediated stimulus. Importantly, a two to five-fold enhancement in migration was observed in the wild-type PZR-rescue MEF cell line compared to other PZR isoforms in SHP-2 rescue and mutant MEF cell lines. These results demonstrate that the intact PZR cytoplasmic domain containing the ITIM-motifs is important in modulating fibronectin-mediated cell migration rates, in these murine mesenchymal derived MEF cells.
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DISCUSSION
PZR has previously been identified as a SHP-2 binding partner in epithelial cells [17] . In this paper, we report the identification and cloning of two novel isoforms of PZR, PZRa and PZRb, and demonstrate that these three isoforms are differentially expressed in the hematopoietic lineage and in stromal/mesenchymal cells. Of particular interest is the observation that the PZR isoforms are more strongly expressed on CD34 + CD38 + clonogenic haematopoietic precursors than in more primitive CD34 + CD38 lo/-pre-CFU precursors. Furthermore, PZR predominates over PZRb in endothelial cells. In addition, a switch occurs during monocytic differentiation when the ratio of PZR increases relative to PZRb. In mesenchymal cells and osteoblasts, PZR is the major isoform.
The significance of the alteration in expression of the PZR isoforms during monocytic differentiation appears to be related to the structural differences between the different isoforms. integrins [8, 9, 35] . SHP-2 physically interacts with and is tyrosine phosphorylated by the c-kit receptor tyrosine kinase upon of SCF ligand binding to hematopoietic and embryonic stem (ES) cells [36] . Treatment of ES cells with SCF induces Erk kinase activation, but this induction is completely blocked in shp-2 -/-ES cells. SHP-2 also interacts with the common gp130 subunit of the IL-6, LIF and oncostatin M receptors [8, 12] . Thus, mutant ES cells lacking the SHP-2 binding site in either SHP-2 or gp130 have impaired abilities to differentiate in vitro [37] . It has also been shown that SHP-2 has an important role in cell motility. Shp-2 mutant cells have defects in migration as well as spreading and have an increased number of focal adhesions [38] . pathways that promote migration by reducing integrin-mediated adhesion. Thus, integrin engagement by fibronectin may lead to tyrosine phosphorylation of PZR, and recruitment and activation of SHP-2, which then induces dephosphorylation events to induce turnover of focal adhesions, reduced adhesion and increased cell motility. Our studies, therefore indicate that the cytoplasmic region of PZR containing ITIMs plays an important role in regulating integrinmediated cell motility and that truncated forms of PZR lacking ITIMs fail to regulate cell motility.
Recent studies [31] + or lo/-cells in the CD34 + fraction R1 and after normalization of values for clonogenic cell output to the CD34 + subset to 100%. C: Cells from 2 donors B and Z sorted into fractions R1, R2 and R3 were also assayed for their content of pre-CFU as described in the Materials and Methods. Data represent the fold expansion of nucleated cells after 1000 cells from each fraction was cultured in 6HGF for up to 35 days.
